Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Kristina Zec

Working in the Udalova Group, the 36-month fellowship will enable Kristina to also assess some novel approaches to limiting disease by a combination of therapeutics and diet.  

Kristina said: “I am extremely happy and honoured to have received a Versus Arthritis Foundation Fellowship. The project I have developed with Irina’s support has translational potential and will significantly expand our understanding of RA pathology. It will dissect the lipid cues involved in communication between gatekeeping macrophages and neutrophils in arthritis. 

“I believe that lipid language can be modified through changing lipid composition of cellular membranes and by altering lipid processing.  I plan to explore these two ways of changing the lipid language of inflammation to discover and deliver novel treatments.  I am excited to embark on a quest of answering these questions in a highly supportive and inspiring environment of my group and the Kennedy Institute." 

Similar stories

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.

Vascular loss shown to be the primary hallmark of aging

Kennedy Main Tissue remodelling and regeneration

New Research from the Kusumbe group at the Kennedy Institute of Rheumatology identifies vascular attrition, marked by pericyte to fibroblast differentiation, as a primary hallmark of aging and highlights organ-specific vascular changes with age.